Blood thinner may reduce death risk in moderately ill COVID-19 patients: Study

A study has said administering a full dose of a standard blood thinner early to moderately ill hospitalised patients with Covid-19 could reduce the risk of severe disease and death.

Administering a full dose of a standard blood thinner early to moderately ill hospitalised patients with Covid-19 could halt the formation of blood clots and reduce the risk of severe disease and death, according to a study. Covid-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death.